Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients

被引：33

作者：

Ferra, Christelle ^{[1
]}

Sanz, Jaime ^{[2
]}

Diaz-Perez, Miguel-Angel ^{[3
]}

Morgades, Mireia ^{[1
]}

Gayoso, Jorge ^{[4
]}

Cabrera, Jose-Rafael ^{[5
]}

Villaescusa, Teresa ^{[6
]}

Sampol, Maria-Antonia ^{[7
]}

Fernandez-Aviles, Francesc ^{[8
]}

Solano, Carlos ^{[9
]}

Ortin, Miguel ^{[10
]}

Duarte, Rafael ^{[11
]}

Cuesta, Marian ^{[12
]}

Heras, Inmaculada ^{[13
]}

de la Serna, Javier ^{[14
]}

Moraleda, Jose-Maria ^{[15
]}

Barrenetxea, Cristina ^{[16
]}

Gonzalez-Vicent, Marta ^{[3
]}

Sanz, Guillermo ^{[2
]}

Ribera, Josep-Maria ^{[1
]}

机构：

[1] Hosp Badalona Germans Trias & Pujol, Dept Hematol, Inst Catala Oncol, Josep Carreras Res Inst, Badalona, Spain

[2] Hosp La Fe, Dept Hematol, E-46009 Valencia, Spain

[3] Hosp Nino Jesus, Dept Hematol, Madrid, Spain

[4] Hosp Gen Gregorio Maranon, Dept Hematol, Madrid, Spain

[5] Hosp Puerta Hierro, Dept Hematol, Madrid, Spain

[6] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain

[7] Hosp Son Espases, Dept Hematol, Palma de Mallorca, Spain

[8] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[9] Hosp Clin Univ, Dept Hematol, Valencia, Spain

[10] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain

[11] Hosp Duran & Reynals, Dept Hematol, Inst Catala Oncol, Lhospitalet De Llobregat, Spain

[12] Hosp Carlos Haya, Dept Hematol, Malaga, Spain

[13] Hosp Morales Meseguer, Dept Hematol, Murcia, Spain

[14] Hosp 12 Octubre, Dept Hematol, Madrid, Spain

[15] Hosp Virgen Arreixaca, Dept Hematol, Murcia, Spain

[16] Hosp Valle De Hebron, Dept Hematol, Barcelona, Spain

来源：

LEUKEMIA & LYMPHOMA | 2015年 / 56卷 / 03期

关键词：

Graft failure; hematopoietic stem cell transplant; outcome; infectious complications; CORD BLOOD TRANSPLANTATION; PERIPHERAL-BLOOD; BONE-MARROW; ENGRAFTMENT; FLUDARABINE; REJECTION; RELAPSE; GVHD;

D O I：

10.3109/10428194.2014.930849

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Strategies for reversing graft failure (GF) after allogeneic stem cell transplant (SCT) depend on the options available in each situation. GF was reported in 16 Spanish institutions from January 2006 to July 2011. Primary GF was defined as an absolute neutrophil count (ANC) > 0.5 x 10(9)/L not reached by day + 28 after SCT from peripheral blood (PB) or bone marrow (BM) progenitors and by day + 42 after SCT from unrelated cord blood (UCB) progenitors. Secondary GF was defined as a recurrent ANC < 0.5 x 10(9)/L. Eighty-nine patients with GF were reported, and 80 patients received a second SCT. The 5-year survival probability was 31% (95% confidence interval [CI]: 18-44%), and the incidences of non-relapse mortality and relapse estimated by competing risks were 47% (95% CI: 36-58%) and 21% (95% CI: 4-28%). The strategy adopted to treat GF was heterogeneous, and no approach could be unequivocally recommended for this situation. The prognosis of patients with GF was poor even after successful recovery from GF.

引用

页码：656 / 662

页数：7

共 50 条

[41] Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation
Harada, Kaito
Najima, Yuho
Kato, Motohiro
Fuji, Shigeo
Shinohara, Akihito
Nakamae, Hirohisa
Toyosaki, Masako
Ashiarai, Miho
Onizuka, Makoto
Hashii, Yoshiko
Ichinohe, Tatsuo
Atsuta, Yoshiko
Nakasone, Hideki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (05) : 744 - 753
[42] Mixed Chimerism and Secondary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia
Kako, Shinichi
Yamazaki, Hirohito
Ohashi, Kazuteru
Ozawa, Yukiyasu
Ota, Shuichi
Kanda, Yoshinobu
Maeda, Tetsuo
Kato, Jun
Ishiyama, Ken
Matsuoka, Ken-ichi
Miyamoto, Toshihiro
Iida, Hiroatsu
Ikegame, Kazuhiro
Fukuda, Takahiro
Ichinohe, Tatsuo
Atsuta, Yoshiko
Mori, Takehiko
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : 445 - 450
[43] A Characterization of the Oral Microbiome in Allogeneic Stem Cell Transplant Patients
Ames, Nancy J.
Sulima, Pawel
Ngo, Thoi
Barb, Jennifer
Munson, Peter J.
Paster, Bruce J.
Hart, Thomas C.
PLOS ONE, 2012, 7 (10):
[44] CT Findings of Late-Onset Noninfectious Pulmonary Complications in Patients With Pathologically Proven Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant
Song, Inyoung
Yi, Chin A.
Han, Joungho
Kim, Dong Hwan
Lee, Kyung Soo
Kim, Tae Sung
Chung, Myung Jin
AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (03) : 581 - 587
[45] Graft versus Leukemia Reactivity after Allogeneic Stem Cell Transplantation
Falkenburg, J. H. Frederik
Warren, Edus H.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : S33 - S38
[46] Donor T-cell chimerism and early post-transplant cytomegalovirus viremia in patients treated with myeloablative allogeneic hematopoietic stem cell transplant
Taimur, S.
Askar, M.
Sobecks, R.
Rybicki, L.
Warshawsky, I.
Mossad, S.
TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (01) : 61 - 66
[47] The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant
Alousi, Amin M.
Uberti, Joseph
Ratanatharathorn, Voravit
LEUKEMIA & LYMPHOMA, 2010, 51 (03) : 376 - 389
[48] Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single-center retrospective study
Lv, Wei-Ran
Zhou, Ya
Xu, Jun
Fan, Zhi-Ping
Huang, Fen
Xu, Na
Xuan, Li
Shi, Peng-Cheng
Liu, Hui
Wang, Zhi-Xiang
Sun, Jing
Liu, Qi-Fa
CANCER MEDICINE, 2021, 10 (23): : 8497 - 8506
[49] Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
Wolff, SN
BONE MARROW TRANSPLANTATION, 2002, 29 (07) : 545 - 552
[50] Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML
Niederwieser, Christian
Morozova, Elena
Zubarovskaya, Ludmila
Zabelina, Tatjana
Klyuchnikov, Evgeny
Janson, Dietlinde
Wolschke, Christine
Christopeit, Maximilian
Ayuk, Francis
Moiseev, Ivan
Afanasyev, Boris V.
Kroger, Nicolaus
BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2834 - 2841

← 1 2 3 4 5 →